Andrew Guggenhime
President and CFO
CFO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vaxcyte, Inc. (PCVX) | President and Chief Financial Officer | $620,000 | $6,072,939 |
| 2024 | Vaxcyte, Inc. (PCVX) | President and Chief Financial Officer | $556,000 | $17,878,117 |
| 2023 | Vaxcyte, Inc. (PCVX) | President and Chief Financial Officer | $517,000 | $5,415,277 |
| 2022 | Vaxcyte, Inc. (PCVX) | President and Chief Financial Officer | $493,658 | $6,902,093 |
| 2021 | Vaxcyte, Inc. (PCVX) | President and Chief Financial Officer | $472,400 | $2,753,001 |
| 2020 | Vaxcyte, Inc. (PCVX) | President and Chief Financial Officer | $274,792 | $5,650,072 |
Earnings-call appearances
-
Vaxcyte, Inc. Q4 FY2025 Earnings Call2026-02-24
Vaxcyte, Inc. (PCVX)
-
Vaxcyte, Inc. Q4 FY2024 Earnings Call2025-03-31
Vaxcyte, Inc. (PCVX)
-
Vaxcyte, Inc. Q4 FY2023 Earnings Call2024-02-27
Vaxcyte, Inc. (PCVX)
-
Vaxcyte, Inc. Q4 FY2022 Earnings Call2023-04-17
Vaxcyte, Inc. (PCVX)
-
Vaxcyte, Inc. Q4 FY2021 Earnings Call2022-02-28
Vaxcyte, Inc. (PCVX)
-
Vaxcyte, Inc. Q4 FY2020 Earnings Call2021-03-29
Vaxcyte, Inc. (PCVX)